Our recent work demonstrated that the breast tumor-initiating cell marker CD44 is highly enriched in CTC clusters and predicts an unfavorable overall survival of patients with breast cancer, especially TNBC (Liu et al., 2019). This evidence concerns the gene CD44 and breast neoplasm.